Real-world propensity score comparison of treatment effectiveness of peginterferon beta-1a vs. subcutaneous interferon beta-1a, glatiramer acetate, and teriflunomide in patients with relapsing-remitting multiple sclerosis

Publication date: June 2021Source: Multiple Sclerosis and Related Disorders, Volume 51Author(s): Anthony T Reder, Nancy Arndt, Cortnee Roman, Caroline Geremakis, Jason P Mendoza, Ray Su, Charles Makin, Robin L Avila, Megan C Vignos
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research